SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SciClone Pharmaceuticals (Holdings) Limited has announced the exercise of 283,550 Share Options under their Post-IPO Option Plan, resulting in the issuance of an equivalent number of new shares. This exercise brings the total number of issued shares to 630,826,562, with an additional 65,935,002 Share Options remaining. The company disclosed this information as part of their regulatory obligations under the Hong Kong Code on Takeovers and Mergers.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.